LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
LLY
802.55
-2.25%↓
UNH
569.62
+1.64%↑
NVO
126.83
-0.63%↓
JNJ
160.55
+0.48%↑
MRK
125.13
-0.6%↓
Übersicht
Veränderung der Aktienkurses
24h
Aktuell
Min
3.85
Max
3.97
Empfehlungen | Starkes Kaufsignal |
---|---|
12-Monats-Prognose | +9.82 upside |
Nächstes Ergebnis | 1. Aug. 2024 |
---|
Technischer Score
By Trading Central
Vertrauen
Weak Bullish Evidence
3.69 / 3.9 Unterstützung & Widerstand
Arbutus Biopharma Corp Chart
Ähnliche Nachrichten
24. Juli 2024, 23:59 UTC
SK Hynix Second-Quarter Profit Surges on AI Chip Sales -- Update
DJ
Lesen
24. Juli 2024, 23:55 UTC
Stocks to Watch: Ford, IBM, Chipotle, Warner Bros
DJ
Lesen
24. Juli 2024, 23:43 UTC
SK Hynix Delivers Another Profitable Quarter
DJ
Lesen
24. Juli 2024, 23:00 UTC
Macquarie Group 1Q Profit In Line With Expectations
DJ
Lesen
24. Juli 2024, 22:16 UTC
Wal-Mart de Mexico 2Q Net Profit Rises 9.3%
DJ
Lesen
24. Juli 2024, 23:30 UTC
RBA Is Warned Rate Hike Would Snuff Out Confidence -- Market Talk
DJ
Lesen
24. Juli 2024, 23:22 UTC
SK Hynix 2Q Net Profit Beat FactSet-Compiled Consensus
DJ
Lesen
24. Juli 2024, 23:22 UTC
SK Hynix 2Q Oper Pft KRW5.469T Vs. Loss KRW2.882T >000660.SE
DJ
Lesen
24. Juli 2024, 23:22 UTC
SK Hynix 2Q Net KRW4.120T Vs. Loss KRW2.988T >000660.SE
DJ
Lesen
24. Juli 2024, 23:21 UTC
SK Hynix 2Q Rev KRW16.423T Vs. KRW7.306T >000660.SE
DJ
Lesen
24. Juli 2024, 23:02 UTC
South Korea's Economy Slows Sharply in Second Quarter
DJ
Lesen
24. Juli 2024, 22:44 UTC
Sandfire: Debt Reduction Helped by Deferral of Motheo Capex Into FY25
DJ
Lesen
24. Juli 2024, 22:43 UTC
Sandfire 4Q Net Debt A$396 Mln, Down 18% on 3Q
DJ
Lesen
24. Juli 2024, 22:43 UTC
Sandfire 4Q Capital Expenditure A$63 Million, Up 17% on 3Q
DJ
Lesen
24. Juli 2024, 22:43 UTC
Sandfire 4Q Unaudited Underlying Ebitda A$360 Million
DJ
Lesen
24. Juli 2024, 22:42 UTC
Sandfire 4Q Unaudited Sales Revenue A$935 Million
DJ
Lesen
24. Juli 2024, 22:40 UTC
Sandfire 4Q Silver Output 1.2 Million Oz, Up 32% on 3Q
DJ
Lesen
24. Juli 2024, 22:40 UTC
Sandfire 4Q Lead Output 1,917 Tons, Up 36% on 3Q
DJ
Lesen
24. Juli 2024, 22:40 UTC
Sandfire 4Q Zinc Output 21,674 Tons, Up 17% on 3Q
DJ
Lesen
24. Juli 2024, 22:39 UTC
Sandfire Resources 4Q Copper Output 27,313 Tons, Up 9% on 3Q
DJ
Lesen
24. Juli 2024, 22:25 UTC
Lazard's Earnings Are an Early Test of CEO's Turnaround Effort -- Barrons.com
DJ
Lesen
24. Juli 2024, 22:20 UTC
Macquarie Says It Remains Well-Positioned to Deliver Superior Performance in Medium Term
DJ
Lesen
24. Juli 2024, 22:20 UTC
Macquarie Says It Continues to Maintain a Conservative Approach to Capital, Funding and Liquidity
DJ
Lesen
24. Juli 2024, 22:19 UTC
Macquarie Says It Continues to Maintain a Cautious Stance
DJ
Lesen
24. Juli 2024, 22:19 UTC
Macquarie Capital Private Credit Portfolio Over $A21.5 Billion at End-June
DJ
Lesen
24. Juli 2024, 22:18 UTC
Macquarie Capital 1Q Investment-Related Income Down on Pcp
DJ
Lesen
24. Juli 2024, 22:18 UTC
Macquarie Capital 1Q Fee and Commission Income Up on Pcp
DJ
Lesen
24. Juli 2024, 22:18 UTC
Macquarie: Commodities Unit 1Q Performance Up on Pcp
DJ
Lesen
24. Juli 2024, 22:17 UTC
Macquarie: Banking Unit Business Banking Loan Portfolio of $A16.6 Bln at End-June, Up 5% on End-March
DJ
Lesen
24. Juli 2024, 22:16 UTC
Macquarie: Banking Unit Funds on Platform of $A142.4 Billion at End-June, Flat on End-March
DJ
Lesen
Peer-Vergleich
Kursveränderung
Arbutus Biopharma Corp Prognose
Kursziel
By TipRanks
12-Monats-Prognose
Durchschnitt 4.25 USD 9.82%
Hoch 5 USD
Tief 4 USD
Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Arbutus Biopharma Corp – Dist angeboten haben.
Rating-Konsens
By TipRanks
Starkes Kaufsignal
4 ratings
3
Buy
1
Halten
0
Sell
Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Arbutus Biopharma Corp – Dist abgegeben haben.
Technischer Score
By Trading Central
Kurzfristig
Weak Bullish Evidence
Recent bullish events outweigh bearish events.
Mittelfristig
Bullish Evidence
All events are bullish.
Langfristig
Bullish Evidence
Bullish events outweigh bearish events.